These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28455832)

  • 21. Identification of biologic agents to neutralize the bicomponent leukocidins of
    Chan R; Buckley PT; O'Malley A; Sause WE; Alonzo F; Lubkin A; Boguslawski KM; Payne A; Fernandez J; Strohl WR; Whitaker B; Lynch AS; Torres VJ
    Sci Transl Med; 2019 Jan; 11(475):. PubMed ID: 30651319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential Interaction of the Staphylococcal Toxins Panton-Valentine Leukocidin and γ-Hemolysin CB with Human C5a Receptors.
    Spaan AN; Schiepers A; de Haas CJ; van Hooijdonk DD; Badiou C; Contamin H; Vandenesch F; Lina G; Gerard NP; Gerard C; van Kessel KP; Henry T; van Strijp JA
    J Immunol; 2015 Aug; 195(3):1034-43. PubMed ID: 26091719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structurally designed attenuated subunit vaccines for S. aureus LukS-PV and LukF-PV confer protection in a mouse bacteremia model.
    Karauzum H; Adhikari RP; Sarwar J; Devi VS; Abaandou L; Haudenschild C; Mahmoudieh M; Boroun AR; Vu H; Nguyen T; Warfield KL; Shulenin S; Aman MJ
    PLoS One; 2013; 8(6):e65384. PubMed ID: 23762356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity.
    Seilie ES; Bubeck Wardenburg J
    Semin Cell Dev Biol; 2017 Dec; 72():101-116. PubMed ID: 28445785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intermolecular ionic interactions serve as a possible switch for stem release in the staphylococcal bi-component toxin for β-barrel pore assembly.
    Takeda K; Tanaka Y; Abe N; Kaneko J
    Toxicon; 2018 Dec; 155():43-48. PubMed ID: 30312693
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Berends ETM; Zheng X; Zwack EE; Ménager MM; Cammer M; Shopsin B; Torres VJ
    mBio; 2019 Jan; 10(1):. PubMed ID: 30602580
    [No Abstract]   [Full Text] [Related]  

  • 27. alpha-Hemolysin, gamma-hemolysin, and leukocidin from Staphylococcus aureus: distant in sequence but similar in structure.
    Gouaux E; Hobaugh M; Song L
    Protein Sci; 1997 Dec; 6(12):2631-5. PubMed ID: 9416613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes.
    Kaneko J; Kamio Y
    Biosci Biotechnol Biochem; 2004 May; 68(5):981-1003. PubMed ID: 15170101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LukMF' is the major secreted leukocidin of bovine Staphylococcus aureus and is produced in vivo during bovine mastitis.
    Vrieling M; Boerhout EM; van Wigcheren GF; Koymans KJ; Mols-Vorstermans TG; de Haas CJ; Aerts PC; Daemen IJ; van Kessel KP; Koets AP; Rutten VP; Nuijten PJ; van Strijp JA; Benedictus L
    Sci Rep; 2016 Nov; 6():37759. PubMed ID: 27886237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukocidins: staphylococcal bi-component pore-forming toxins find their receptors.
    Spaan AN; van Strijp JAG; Torres VJ
    Nat Rev Microbiol; 2017 Jul; 15(7):435-447. PubMed ID: 28420883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. lukSF-PV in Staphylococcus aureus keratitis isolates and association with clinical outcome.
    Sueke H; Shankar J; Neal T; Winstanley C; Tuft S; Coates R; Horsburgh MJ; Kaye S;
    Invest Ophthalmol Vis Sci; 2013 May; 54(5):3410-6. PubMed ID: 23580488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Staphylococcus aureus leukotoxin GH promotes formation of neutrophil extracellular traps.
    Malachowa N; Kobayashi SD; Freedman B; Dorward DW; DeLeo FR
    J Immunol; 2013 Dec; 191(12):6022-9. PubMed ID: 24190656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Separately or combined, LukG/LukH is functionally unique compared to other staphylococcal bicomponent leukotoxins.
    Yanai M; Rocha MA; Matolek AZ; Chintalacharuvu A; Taira Y; Chintalacharuvu K; Beenhouwer DO
    PLoS One; 2014; 9(2):e89308. PubMed ID: 24586678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective Efficacy of Monoclonal Antibodies Neutralizing Alpha-Hemolysin and Bicomponent Leukocidins in a Rabbit Model of Staphylococcus aureus Necrotizing Pneumonia.
    Vu TTT; Nguyen NTQ; Tran VG; Gras E; Mao Y; Jung DH; Tkaczyk C; Sellman BR; Diep BA
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844012
    [No Abstract]   [Full Text] [Related]  

  • 35. Counter inhibition between leukotoxins attenuates Staphylococcus aureus virulence.
    Yoong P; Torres VJ
    Nat Commun; 2015 Sep; 6():8125. PubMed ID: 26330208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Commercial Intravenous Immunoglobulin Preparations Contain Functional Neutralizing Antibodies against the Staphylococcus aureus Leukocidin LukAB (LukGH).
    Wood JB; Jones LS; Soper NR; Nagarsheth M; Creech CB; Thomsen IP
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro production of panton-valentine leukocidin among strains of methicillin-resistant Staphylococcus aureus causing diverse infections.
    Hamilton SM; Bryant AE; Carroll KC; Lockary V; Ma Y; McIndoo E; Miller LG; Perdreau-Remington F; Pullman J; Risi GF; Salmi DB; Stevens DL
    Clin Infect Dis; 2007 Dec; 45(12):1550-8. PubMed ID: 18190315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study of the Penetration of a Monoclonal Antibody Combination (ASN100) Targeting
    Magyarics Z; Leslie F; Bartko J; Rouha H; Luperchio S; Schörgenhofer C; Schwameis M; Derhaschnig U; Lagler H; Stiebellehner L; Firbas C; Weber S; Campanaro E; Jilma B; Nagy E; Stevens C
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The N-terminal amino-latch region of Hlg2 component of staphylococcal bi-component γ-haemolysin is dispensable for prestem release to form β-barrel pores.
    Takeda K; Tanaka Y; Kaneko J
    J Biochem; 2020 Oct; 168(4):349-354. PubMed ID: 32330256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rim domain loops of staphylococcal β-pore forming bi-component toxin S-components recognize target human erythrocytes in a coordinated manner.
    Peng Z; Takeshita M; Shibata N; Tada H; Tanaka Y; Kaneko J
    J Biochem; 2018 Aug; 164(2):93-102. PubMed ID: 29474554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.